Gene · 2285
Papers2,250
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,250
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Biosynthesis of ansamitocin P-3 incurs stress on the producing strain Actinosynnema pretiosum at multiple targets. | Commun Biol | 2023 | 37596387 | PubTator, text mining | PubMed |
| Regulation of CD8+ T memory and exhaustion by the mTOR signals. | Cell Mol Immunol | 2023 | 37582972 | PubTator, text mining | PubMed |
| Transient conformations in the unliganded FK506 binding domain of FKBP51 correspond to two distinct inhibitor-bound states. | J Biol Chem | 2023 | 37579948 | PubTator, text mining | PubMed |
| A review of FDA approved drugs and their formulations for the treatment of breast cancer. | Front Pharmacol | 2023 | 37576816 | PubTator, text mining | PubMed |
| Computational and Experimental Analyses for Pathogenicity Prediction of ACVRL1 Missense Variants in Hereditary Hemorrhagic Telangiectasia. | J Clin Med | 2023 | 37568404 | PubTator, text mining | PubMed |
| Implication of mTOR Signaling in NSCLC: Mechanisms and Therapeutic Perspectives. | Cells | 2023 | 37566093 | PubTator, text mining | PubMed |
| Seizure reduction in TSC2-mutant mouse model by an mTOR catalytic inhibitor. | Ann Clin Transl Neurol | 2023 | 37545094 | PubTator, text mining | PubMed |
| Proximity-Based Modalities for Biology and Medicine. | ACS Cent Sci | 2023 | 37521793 | PubTator, text mining | PubMed |
| Creation of Artificial Luciferase 60s from Sequential Insights and Their Applications to Bioassays. | Sensors (Basel) | 2023 | 37514669 | PubTator, text mining | PubMed |
| Exploring the mTOR Signalling Pathway and Its Inhibitory Scope in Cancer. | Pharmaceuticals (Basel) | 2023 | 37513916 | PubTator, text mining | PubMed |
| Subcellular Expression Patterns of FKBP Prolyl Isomerase 10 (FKBP10) in Colorectal Cancer and Its Clinical Significance. | Int J Mol Sci | 2023 | 37511172 | PubTator, text mining | PubMed |
| Polypeptide Substrate Accessibility Hypothesis: Gain-of-Function R206H Mutation Allosterically Affects Activin Receptor-like Protein Kinase Activity. | Biomolecules | 2023 | 37509165 | PubTator, text mining | PubMed |
| Reverse-ChIP Techniques for Identifying Locus-Specific Proteomes: A Key Tool in Unlocking the Cancer Regulome. | Cells | 2023 | 37508524 | PubTator, text mining | PubMed |
| Proline Isomerization: From the Chemistry and Biology to Therapeutic Opportunities. | Biology (Basel) | 2023 | 37508437 | PubTator, text mining | PubMed |
| Proteolysis-Targeting Chimera (PROTAC) Delivery into the Brain across the Blood-Brain Barrier. | Antibodies (Basel) | 2023 | 37489365 | PubTator, text mining | PubMed |
| Collateral lethality between HDAC1 and HDAC2 exploits cancer-specific NuRD complex vulnerabilities. | Nat Struct Mol Biol | 2023 | 37488358 | PubTator, text mining | PubMed |
| Beyond canonical PROTAC: biological targeted protein degradation (bioTPD). | Biomater Res | 2023 | 37480049 | PubTator, text mining | PubMed |
| Bifunctional small molecules that induce nuclear localization and targeted transcriptional regulation. | bioRxiv | 2023 | 37461636 | PubTator, text mining | PubMed |
| Assay methods based on proximity-enhanced reactions for detecting non-nucleic acid molecules. | Front Bioeng Biotechnol | 2023 | 37456730 | PubTator, text mining | PubMed |
| A method for polyclonal antigen-specific T cell-targeted genome editing (TarGET) for adoptive cell transfer applications. | Mol Ther Methods Clin Dev | 2023 | 37448595 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2285/papers?page=9